{
    "clinical_study": {
        "@rank": "149683", 
        "arm_group": [
            {
                "arm_group_label": "Biological Maternal Sounds", 
                "arm_group_type": "Experimental", 
                "description": "Daily Exposure to recorded mother's voice and heartbeat sounds via audio systems installed at the bedside"
            }, 
            {
                "arm_group_label": "Hospital Sounds", 
                "arm_group_type": "Sham Comparator", 
                "description": "Exposure to standard hospital sounds; routine care."
            }
        ], 
        "brief_summary": {
            "textblock": "The purpose of this RCT is to learn more about how sounds that we experience in the womb can\n      affect early development in premature infants. The investigators are specifically interested\n      determining whether and what types of maternal sensory stimulation can influence physical\n      growth, brain maturation, respiratory stability and early vocalization during postnatal\n      development. The investigators hypothesize that daily exposure to biological maternal\n      sounds, such as mother's voice and heartbeat, will improve both short-term and long-term\n      developmental  in premature infants and will increase their potential to grow into healthy\n      children."
        }, 
        "brief_title": "Effects of Mother's Voice and Heartbeat Sounds on Preterm Newborns", 
        "completion_date": {
            "#text": "December 2019", 
            "@type": "Anticipated"
        }, 
        "condition": "Preterm Birth", 
        "condition_browse": {
            "mesh_term": "Premature Birth"
        }, 
        "detailed_description": {
            "textblock": "The purpose of this RCT is to learn more about how sounds that we experience in the womb can\n      affect early development in premature infants. The investigators are specifically interested\n      determining whether and what types of maternal auditory stimulation  can influence physical\n      growth, brain maturation, respiratory stability (including heart rate, respiratory rate and\n      oxygen saturation levels) as well as early vocalization prior to 40 weeks gestation. The\n      investigators hypothesize that daily exposure to biological maternal sounds, such as\n      mother's voice and heartbeat, will improve both short-term and long-term developmental\n      outcomes in premature infants and will increase their potential to grow into healthy\n      children."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Born between 24-36 weeks GA.\n\n        Exclusion Criteria:\n\n          -  Chromosomal or congenital anomalies; congenital infections; > grade II IVH;\n\n          -  maternal use of tobacco, alcohol, or illicit drugs;\n\n          -  significant abuse or malnutrition during pregnancy,\n\n          -  failed ABR.\n\n          -  No exclusions based on gender or ethnicity."
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "34 Weeks", 
            "minimum_age": "24 Weeks"
        }, 
        "enrollment": {
            "#text": "150", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "May 16, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01913288", 
            "org_study_id": "2009p000936"
        }, 
        "intervention": {
            "arm_group_label": [
                "Biological Maternal Sounds", 
                "Hospital Sounds"
            ], 
            "description": "n/a", 
            "intervention_name": "Biological Maternal Sounds", 
            "intervention_type": "Other"
        }, 
        "is_fda_regulated": "No", 
        "keyword": "neonatal care, preterm, maternal sounds, auditory stimulation", 
        "lastchanged_date": "July 31, 2013", 
        "location": {
            "contact": {
                "email": "phughes@partners.org", 
                "last_name": "Paul Hughes"
            }, 
            "facility": {
                "address": {
                    "city": "Boston", 
                    "country": "United States", 
                    "state": "Massachusetts", 
                    "zip": "02115"
                }, 
                "name": "Brigham and Women's Hospital"
            }, 
            "investigator": {
                "last_name": "Amir Lahav, ScD", 
                "role": "Principal Investigator"
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "United States"
        }, 
        "number_of_arms": "2", 
        "official_title": "Exposure to Biological Maternal Sounds in Extremely Preterm Infants: Effects on Short- and Long-term Outcomes", 
        "overall_contact": {
            "email": "amir@hms.harvard.edu", 
            "last_name": "Amir Lahav, ScD"
        }, 
        "overall_official": {
            "affiliation": "Brigham and Women's Hospital", 
            "last_name": "Amir Lahav, ScD", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "United States: Institutional Review Board", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "December 2018", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": [
            {
                "description": "Data will be obtained by an MRI brain scan and will be calculated separately for white matter, grey matter, CSF.", 
                "measure": "Brain volume (DM^3)", 
                "safety_issue": "No", 
                "time_frame": "Between 36-40 weeks gestation"
            }, 
            {
                "description": "Data will be obtained using the MacArthur-Bates Communicative Development Inventories (CDI), the Receptive-Expressive Emergent Language Test Third Edition (REEL-3), and the Bayley Scales of Infant Development Third Edition (Bayley-III).", 
                "measure": "Language and cognitive skills", 
                "safety_issue": "No", 
                "time_frame": "At 12 and 24 months corrected-age"
            }
        ], 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01913288"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Brigham and Women's Hospital", 
            "investigator_full_name": "Amir Lahav", 
            "investigator_title": "Instructor in Pediatrics", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": [
            {
                "description": "Data will be collected from the bedside cardiac monitor", 
                "measure": "Oxygen saturation levels (mg/l)", 
                "safety_issue": "No", 
                "time_frame": "participants will be followed for the duration of hospital stay, an expected average of 6 weeks"
            }, 
            {
                "description": "Data will be collected from the bedside cardiac monitor", 
                "measure": "Heart rate (BPM)", 
                "safety_issue": "No", 
                "time_frame": "participants will be followed for the duration of hospital stay, an expected average of 6 weeks"
            }, 
            {
                "description": "Data will be obtained by real-time recording of the language environment", 
                "measure": "Infant vocalization (word count)", 
                "safety_issue": "No", 
                "time_frame": "Between 32-36 weeks gesation"
            }, 
            {
                "description": "Data will be obtained from medical records", 
                "measure": "Weight gain (gr/kg/day)", 
                "safety_issue": "No", 
                "time_frame": "participants will be followed for the duration of hospital stay, an expected average of 6 weeks"
            }
        ], 
        "source": "Brigham and Women's Hospital", 
        "sponsors": {
            "collaborator": [
                {
                    "agency": "Charles H. Hood Foundation", 
                    "agency_class": "Other"
                }, 
                {
                    "agency": "Peter and Elizabeth C. Tower Foundation", 
                    "agency_class": "Other"
                }
            ], 
            "lead_sponsor": {
                "agency": "Brigham and Women's Hospital", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "May 2013", 
        "study_design": "Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "July 2013"
    }
}